Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 13,240 shares at $55.61 ($737K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $737k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.61 | 6,470 | $360K | 48.9% |
| 2 | $55.61 | 6,470 | $360K | 48.9% |
| 3 | $56.41 | 300 | $17K | 2.3% |
| Total | $55.63 avg | 13,240 | $737K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |